Amniotic Tissue Injections

Amniotic Tissue Injections

What are Amniotic Tissue Injections?

Mesenchymal stem cells, which play a crucial role in intercellular communication, generate extracellular vesicles called exosomes. Other cells receive and act upon the message signals conveyed by these exosomes, leading to changes in their behavior. Scientists can now directly administer these beneficial signalers instead of relying on stem cells.

 

By utilizing proprietary processing, scientists extract and refine exosomes from human amniotic mesenchymal stem cells that have been donated. Since these exosomes originate from stem cells, they contain a diverse range of growth factors. Due to their small and agile size, exosomes can discreetly travel within the bloodstream and carry multiple doses of proteins across cellular barriers that are typically impenetrable.

 

Donor ethics and non-reactive FDA approved serological screening includes:

How are exosome treatments different from PRP (Platelet Rich Plasma) treatments?

Platelet Rich Plasma (PRP) is a process where a patient’s blood is centrifuged to increase the concentration of growth factors and platelets that are naturally present. However, PRP does not contain any stem cells or exosomes as these tend to diminish in quantity as we age.

 

PRP treatment concentrates on growth factors and platelets only, which are then injected into the patient. It is important to note that PRP is often mistaken for concentrated stem cells, but blood is not an ideal source for stem cells. Initially, stem cells were extracted from fat gathered during liposuction; however, the process is intensive and not practical, particularly considering the reduced potency of stem cells obtained from aging patients.

Yes. The exosomes are tested for several diseases including HIV, Hepatitis, and others. Each of the packages contains the findings of the tests conducted.

Exosomes release their message within 24 hours and don’t remain in tissue, but the associated miRNA and mRNA can persist.

After the procedure, there are minimal restrictions, and patients can usually resume their daily routine or work. Normal exercise and activities are also permitted. However, it is recommended to avoid using aspirin, Naproxen, Ibuprofen, and other NSAIDs for up to four days.

 

Patients are advised to:

  • Drink plenty of fluids one day before the procedure. 

  • Refrain from using Aspirin, Naproxen, Ibuprofen, and other NSAIDs for at least four days before and after the procedure.